Latest Views...
Shortage of drugs led pharmacists to warn "the consequences could be further hospital admissions or even fatalities"         "They will not explain their imposed quota system and they will not discuss the issue directly." Shortages were "out of hand and nearing catastrophe" - Andrew McCoig, the chief executive of the NHS pharmaceutical committee for Merton, Sutton         "Before the introduction of manufacturers' quotas, the market for medicines worked effectively. No longer can patients be assured that if they walk into a pharmacy their medication will be available immediately or within an acceptable timescale." - Calderdale and Kirklees local pharmaceutical committee         Four in five NHS trusts in England & Wales say patients are suffering "unacceptable" delays for drugs         Lives at risk by shortage of critical medicines because pharmaceutical companies are rationing drugs, NHS leaders warn         A survey of 60 NHS authorities found that the shortage was doing patients "serious harm", with patients facing delays of up to 6 months - (The Telegraph 22 June 2012)         Imposed rationing to stop sale of drugs abroad has made the shortages much worse, say NHS leaders and pharmacies. - (The Telegraph 22 June 2012)         "The current restriction in supply imposed by drug companies is harming the public and must be addressed urgently." - Prof John Parkes, the chief executive of NHS Milton Keynes and Northamptonshire

WHAT PEOPLE ARE SAYING

 

We sent a Document to every MP with a Questionnaire attached and free post envelope. Our responses were positive and reflected a similar view from most answers.

 

 


 

 


 

Just some of the Responses we have had

 

 

Do you agree there is evidence to suggest that some of the larger pharmaceutical companies are putting profit before the needs of patients?

Do you agree that the regulators including the MHRA they have not enforced the correct articles and laws on the pharmaceutical manufacturing companies?

Unfair restrictions are being put in place to control the movement and distribution of pharmaceuticals within and from the UK. Do you think it is fair that the companies who hold the means of operations should be able to reclassify and restrict drugs in the UK?

Many of the larger companies only spend between 6% - 19% of revenue on R&D, in comparison between 15% - 42% of revenue is spent on marketing. Do you think it is therefore acceptable to price the drugs at high rates, when so little is spent on R&D?

Do you believe that medicines supplied in the UK should be restricted to UK patients only, and conversely that the NHS and UK patients should not be allowed to buy vital medication at a cheaper cost from EU member states?

Email
Password
Success. Please Wait...

Forename
Surname
Email
I agree to be contacted via Email
Thank You.
You have been successfully added to our mailing list.
Success. Please Wait...